On the heels of a string of new cancer licensing deals and biotech buyouts, Sanofi-Aventis says that it is preparing to lease space in Cambridge, MA for a new cancer division headquarters facility that will add about 300 high-paying jobs, according to a report in the Boston Globe.
Sanofi officials made it clear that Cambridge's biotech cluster, home to some of the world's best-known cancer researchers, was a natural choice for the $65 million expansion effort. Sanofi's oncology chief,...